Femasys Inc.
corporate_fare Company Profile
Femasys Inc. (NASDAQ:FEMY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 32 items for FEMY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for FEMY spans 424B3, S-3, 10-Q, 8-K.
Recent high-impact activity:
- Q3 Revenue Falls 45% to $404K, Missing Estimates; Loss Per Share 53 Cents
- Femasys Faces $3.1M Lawsuit Over August Private Placement Terms
- Femasys Registers 28.1M Shares for Resale from $30M Private Placement
- Femasys Partners with UNC Health to Expand FemaSeed Fertility Portfolio Across North Carolina
- FDA Approves Modular PMA Pathway for FemBloc, Clearing Key Hurdle
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 49,266 shares in FEMY as of the October 30, 2026 settlement, a 70.0% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 54.0% of FEMY volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for FEMY, detected from its recent SEC filings · based on capital-structure filings through 2026-09-29.
Lawsuit Filed Over Private Placement · Alleged Fundamental Transaction Breach
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →